Khan, A.; Alsahli, M.A.; Aljasir, M.A.; Maswadeh, H.; Mobark, M.A.; Azam, F.; Allemailem, K.S.; Alrumaihi, F.; Alhumaydhi, F.A.; Alwashmi, A.S.S.;
et al. Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Pharmaceutics 2022, 14, 153.
https://doi.org/10.3390/pharmaceutics14010153
AMA Style
Khan A, Alsahli MA, Aljasir MA, Maswadeh H, Mobark MA, Azam F, Allemailem KS, Alrumaihi F, Alhumaydhi FA, Alwashmi ASS,
et al. Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Pharmaceutics. 2022; 14(1):153.
https://doi.org/10.3390/pharmaceutics14010153
Chicago/Turabian Style
Khan, Arif, Mohammed A. Alsahli, Mohammad A. Aljasir, Hamzah Maswadeh, Mugahid A. Mobark, Faizul Azam, Khaled S. Allemailem, Faris Alrumaihi, Fahad A. Alhumaydhi, Ameen S. S. Alwashmi,
and et al. 2022. "Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer" Pharmaceutics 14, no. 1: 153.
https://doi.org/10.3390/pharmaceutics14010153
APA Style
Khan, A., Alsahli, M. A., Aljasir, M. A., Maswadeh, H., Mobark, M. A., Azam, F., Allemailem, K. S., Alrumaihi, F., Alhumaydhi, F. A., Alwashmi, A. S. S., Almatroudi, A. A., Alsugoor, M. H., & Khan, M. A.
(2022). Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer. Pharmaceutics, 14(1), 153.
https://doi.org/10.3390/pharmaceutics14010153
